A new cannabimimetic phenylacetylindole (cannabipiperidiethanone,
1) has been found as an adulterant in a herbal product which contains two other known synthetic cannabinoids, JWH-122 and JWH-081, and which is distributed illegally in Japan. The identification was based on analyses using GC-MS, LC-MS, high-resolution MS and NMR. Accurate mass spectrum measurement showed the protonated molecular ion peak of
1 at
m/
z 377.2233 [M+H]
+ and the molecular formula of
1 was C
24H
29N
2O
2. Both mass and NMR spectrometric data revealed that
1 was 2-(2-methoxyphenyl)-1-{1-[(1-methylpiperidin-2-yl)methyl]-1
H-indol-3-yl}ethanone. Compound
1 has a mixed structure of known cannabimimetic compounds: JWH-250 and AM-2233. Namely, the moiety of phenylacetyl indole and
N-methylpiperidin-2-yl-methyl correspond to the structure of JWH-250 and AM-2233, respectively. However, no synthetic, chemical or biological information about
1 has been reported. A binding assay of compound
1 to cannabinoid receptors revealed that
1 has affinity for the CB
1 and CB
2 (IC
50=591, 968 n
M, respectively) receptors, and shows 2.3- and 9.4-fold lower affinities than those of JWH-250. This is the first report to identify cannabimimetic compound (
1) as a designer drug and to show its binding affinity to cannabinoid receptors.
View full abstract